Reporter brief
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This is a study protocol or prospective registration with no outcome data; no claims about efficacy or safety can be evaluated.
- The crossover design and comparison between two active interventions (NMN+TMG vs NMN alone) means any positive findings would not establish superiority over placebo for either formulation.
- Sample size, statistical power, and recruitment/completion status are not disclosed, making it impossible to assess whether findings would be statistically reliable.
Study design and sample
Rct; Human.
Healthy older adults
- Design
- Rct
- Sample
- —
- Journal
- Not clearly reported
- Published
- Oct 7, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the NMN timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.